| HOME >> BIOLOGY >> TECHNOLOGY |
About ATS Medical
ATS Medical, Inc. is dedicated to 'Advancing The Standards' of cardiac surgery through the development, manufacturing and marketing of innovative products and services for the treatment of structural heart disease. ATS Medical serves the cardiac surgery community by focusing on two distinct but operationally synergistic market segments: heart valve disease therapy and surgical ablation of cardiac arrhythmias.
ATS was originally founded to develop the ATS Open Pivot(R) Heart Valve as
a new mechanical heart valve standard of care. Today the Open Pivot heart
valve is the preferred mechanical heart valve in many markets around the world
and the fastest growing mechanical prosthesis in the market. Building on this
legacy and addressing the largest market segment in heart valve therapy, the
ATS 3f(R) brand encompasses an innovative tissue heart valve portfolio to
address conventional open surgery requirements as well as the growing demand
for less invasive sutureless based procedures. The ATS 3f(R) portfolio
includes offerings at various stages including early product development,
pivotal clinical trials, and market commercialization. Completing the
portfolio in heart valve therapy is the ATS Simulus(R) annuloplasty product
line. Simulus products assist the surgeon in repairing a patient's native
heart valve as an alternative to replacement. Continuing ATS Medical's focus
on serving the cardiac surgery community are the ATS CryoMaze(TM) products for
surgical cryoablation of cardiac arrhythmias. ATS CryoMaze(TM) products are
used by surgeon
'/>"/>
| SOURCE ATS Medical, Inc. Copyright©2009 PR Newswire. All rights reserved |